These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35708454)

  • 1. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
    Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
    JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Opioid Prescribing by Dentists in the United States and England.
    Suda KJ; Durkin MJ; Calip GS; Gellad WF; Kim H; Lockhart PB; Rowan SA; Thornhill MH
    JAMA Netw Open; 2019 May; 2(5):e194303. PubMed ID: 31125102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
    Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
    JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
    Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
    J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio.
    Liu Y; Baker O; Schuur JD; Weiner SG
    Pain Med; 2020 Sep; 21(9):1863-1870. PubMed ID: 31502638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
    Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
    Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid prescribing by oral and maxillofacial surgeons in the United States, 2016-2019.
    Khouja T; Polk DE; Suda KJ
    J Public Health Dent; 2022 Sep; 82(4):491-494. PubMed ID: 36210548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
    Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
    Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
    Haynes A; Kleinschmidt K; Forrester MB; Young A
    Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.
    Habbouche J; Lee J; Steiger R; Dupree JM; Khalsa C; Englesbe M; Brummett C; Waljee J
    JAMA Surg; 2018 Dec; 153(12):1111-1119. PubMed ID: 30140896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of the impact of Michigan's opioid prescribing legislation on discharge opioid prescribing at a single institution.
    Sadowski R; Hillaker E; Chavarria M; Khaliq F; Schwark A
    J Opioid Manag; 2022; 18(5):467-474. PubMed ID: 36226786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Hydrocodone Misuse Exposures Reported to U.S. Poison Centers Following Rescheduling in 2014.
    Fischer LJ; Severtson SG; Gurrola MC; Iwanicki JL; Green JL; Dart RC
    Subst Use Misuse; 2022; 57(7):1097-1103. PubMed ID: 35450512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a more strict 2014 DEA schedule designation for hydrocodone products on opioid prescription rates in the United States.
    Harrison ML; Walsh TL
    Clin Toxicol (Phila); 2019 Nov; 57(11):1064-1072. PubMed ID: 30789065
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns in opioid prescription in the United States by region and prescribers over a 4-year period.
    Bigal LM; Bibeau K; Dumbar S
    J Opioid Manag; 2019; 15(6):499-506. PubMed ID: 31850512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center.
    Schultz S; Chamberlain C; Vulcan M; Rana H; Patel B; Alexander JC
    J Opioid Manag; 2016; 12(2):119-22. PubMed ID: 27194196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.
    Wu A; Phan C; Nguyen KC; Quindoy M; Lewis J; Apollonio DE
    Clin Toxicol (Phila); 2021 Apr; 59(4):313-319. PubMed ID: 32840386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures.
    Mallama C; Karami S; Zhang D; Zhao Y; Yang Y; Woods C; Ding Y; Meyer T; McAninch J
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5793. PubMed ID: 38783553
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.